MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
Tao Shen(Baylor College of Medicine), Feng Yang(Baylor College of Medicine), Bingning Dong(Baylor College of Medicine), Chad J. Creighton(Baylor College of Medicine), Michael Ittmann(Baylor College of Medicine), Peter S. Nelson(Fred Hutch Cancer Center), Ilsa M. Coleman(Fred Hutch Cancer Center), David D. Moore(University of California, Berkeley), Wei Wang(Ministry of Education of the People's Republic of China), Yingnan Bian(Fudan University), Yan–Ling Meng, Qinbo Cai(Baylor College of Medicine), Wolong Zhou, David R. Rowley(Baylor College of Medicine)
Cited by 62
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
|New England Journal of Medicine|2016|1.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k